| Meet DE Bio |
Meet DE BioOur PurposeWe serve pharmaceutical and biotechnology firms, medical device manufacturers, agricultural biotech and chemical companies, research and testing companies, hospitals and medical institutions, academic partners and other organizations and related service companies, with the goal of expanding our state’s vibrant science economy. Our 200+ member companies and organizations are of every size, from global leaders to small start-ups, representing 11,000 innovation-based jobs vital to Delaware’s economic future. What We Do
Delaware Bio is committed to nurturing and expanding this dynamic community so critical to Delaware’s public and economic health. We do this through:
Board of Directors
Lakshmi Cyr
Department Chair Delaware Technical Community College
Bob Dayton
Honorary Delaware BioScience Association
Brian Haigh
Region Director Avantor, Delivered by VWR
Paula Hietpas, Ph.D.
Associate Vice President, R&D Agilent Technologies
Ben Hsu
Chief Administrative Officer and General Manager QPS, LLC
Kelvin Lee, Ph.D.
Institute Director Manufacturing USA National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)
Sandra Lewisch
Senior Director, R&D Siemens Healthineers
Tim Mueller
Vice President EHS, Lab Operations, & Facilities Prelude Therapeutics
Natalia Rivera-Torres
Principal Investigator ChristianaCare Gene Editing Institute
Bruce Sachais MD, PhD
Senior Vice President, New York Blood Center
Tracy Shickel
Associate Vice President University of Delaware
Helen Stimson
Executive in Residence University of Delaware ![]()
Paula Swain
Executive Vice President of Human Incyte
Shamus Whyte
General Manager AstraZeneca ![]()
Ray Yin
President ANP Technologies Staff Stay Up To Date
Sign up to receive our newsletter, upcoming event notifications, and industry news
Sign Up Now
Our Sponsors |
1/12/2026Wilmington PharmaTech Appoints Seasoned Commercial Leader to Drive Growth
1/12/2026AstraZeneca names insider Rick Suarez as head of US biopharmaceuticals unit
1/12/2026ABS Bio, Inc. acquires Cureline, Inc. to strengthen support of biopharma drug discovery
1/12/2026Foresee Pharmaceuticals spots prostate cancer med's potential in rare puberty disease, touts...
3/19/2026
2026 March BioBreakfast